Santarus

Specialty biopharma company marketing drugs for type II diabetes, ulcerative colitis and others.

placeSan Diego, California, United States calendar_todayFounded 1996 language santarus.com

Innovation

25 patent families (17 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 2,925 times.

YearFilings
20125
20139
20148
20157
20164
20177
20183
20194
20202
20211
20222

Investor mix

13 investors on record; lead investors include SR One; 1 has since exited.

Investor typeCountShare
Venture capital862%
Private equity323%
Other / undisclosed215%
Coming soon